Japanese Company CEOs
/ Ono Pharmaceutical
Ono Pharmaceutical CEOs: 4 Presidents Since 2006
Revenue and CEOs
4 CEOs
Ono Pharmaceutical
CEOs and long-term results
FY2026
Consolidated
Revenue
¥515.8 billion
Net margin
13.5%
Korekane
Sagara
Takino
Revenue
¥5.1 billion
Revenue
¥17.1 billion
Revenue
¥148.7 billion
Revenue
¥160.3 billion
Revenue
¥515.8 billion
Net margin
3.9%
Net margin
2.3%
Net margin
24.3%
Net margin
15.6%
Net margin
13.5%
1966/3
1971/3
1976/3
1981/3
1986/3
1991/3
1996/3
2001/3
2006/3
2011/3
2016/3
2021/3
2026/3
Revenue
¥5.1 billion
Revenue
¥148.7 billion
Revenue
¥515.8 billion
Net margin
3.9%
Net margin
24.3%
Net margin
13.5%
1966/3
1976/3
1986/3
1996/3
2006/3
2016/3
2026/3
API:
/api/4528/financials_history.csv
·
/api/4528/financials/pl.json
Tenure timeline
2000
2010
2020
2030
Toshiharu Korekane
Daikichi Fukushima
Gyo Sagara
Toichi Takino
Presidents
4
Presidents
Name
From
To
Years
Background
Education
Toshiharu Korekane
May 2006
Company veteran
Osaka City University, Faculty of Economics
Daikichi Fukushima
Jun 2008
Company veteran
Gunma University, Graduate School of Engineering, Master's Program (1975)
Gyo Sagara
Sep 2008
Apr 2024
15.6
Company veteran
Toichi Takino
Apr 2024
Present
2.6
Company veteran